Company: SMNR
Filing Date: 2025-08-08
Form Type: S-4/A
Source: 0001193125-25-177097
Chunk: 694

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-08
Form: S-4/A
Chunk 694
---
 and Registrar
Upon the consummation of the Business Combination, the transfer agent and registrar for New Semnur Common Stock will be VStock. The transfer agent’s address is 18 Lafayette Place, Woodmere, New York 11598.

#### Listing
Application has been made for the shares of New Semnur Common Stock and New Semnur Warrants to be approved for listing on Nasdaq under the symbols “SMNR” and “SMNRW” respectively. As of the date hereof, such listing has not been approved and there can be no assurance that New Semnur’s Nasdaq listing application will be approved prior to the Business Combination and New Semnur’s approval to list its securities on Nasdaq is not a closing condition in the Merger Agreement.

<div align='center'>421</div>

SECURITIES ELIGIBLE FOR FUTURE SALE Pursuant to Rule 144 under the Securities Act (“Rule 144”), a person who has beneficially owned restricted common stock or warrants of New Semnur for at least six months would be entitled to sell their securities provided that (i) such person is not deemed to have been an affiliate of New Semnur at the time of, or at any time during the three months preceding, a sale and (ii) New Semnur is subject to the Exchange Act periodic requirements for at least three months before the sale and have filed all required reports under Section 13 or 15(d) of the Exchange Act during the twelve months (or such shorter period as New Semnur was required to file reports) preceding the sale. Persons who have beneficially owned restricted common stock or warrants of New Semnur for at least six months but who are affiliates of New Semnur at the time of, or at any time during the three months preceding, a sale, would be subject to additional restrictions, by which such person would be entitled to sell within any three–month period only a number of securities that does not exceed the greater of:

| • |     | 1% of the total number of restricted New Semnur Common Stock then outstanding; or |

| • |     | the average weekly reported trading volume of New Semnur Common Stock during the four calendar weeks preceding the filing of a notice on Form 144 with respect to the sale. |

Sales by affiliates of New Semnur under Rule 144 are also limited by manner of sale provisions and notice requirements and to the availability of current public information about New Semnur. Restrictions